Alternatives to SonoThera
SonoThera is a Biotechnology tool: developing ultrasound-mediated nonviral genetic medicines. Here are the 2 closest alternatives, compared on pricing, features and what real users say.
The 2 closest alternatives to SonoThera
Ranked by how closely each one overlaps with SonoThera on category and features.
- 1
Spark Therapeutics
BiotechnologyA biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Pricing:
- Contact for pricing
- Reddit:
- 33% positive(3 mentions)how we count
- 2
Developing a new histotripsy therapeutic platform for cancer treatment.
- Pricing:
- Contact for pricing
- Reddit:
- 67% positive(6 mentions)how we count
Community sentiment is our own count of how positive, negative or neutral the discussions we track about each tool are, across the subreddits where its users actually post. It is not a star rating and it is not a review score. Pricing reflects each vendor's public plans and can change, so check the provider for the current price.
We track only 2 close alternatives to SonoThera so far. Browse more Biotechnology alternatives while this list fills out.
The 20 closest Biotechnology companies to SonoThera
- Website
Epicrispr Biotechnologies62BiotechnologySouth San Francisco, United States$90.0MEpicrispr Biotechnologies is a biotechnology company developing novel epigenetic therapies, with a lead program targeting Facioscapulohumeral Muscular Dystrophy (FSHD).
- Website
Mironid59BiotechnologyGlasgow, United Kingdom$46.0MBiopharmaceutical company developing novel small-molecule therapeutics for rare kidney diseases, particularly Autosomal Dominant Polycystic Kidney Disease (ADPKD).
- Website Spark Therapeutics58BiotechnologyPhiladelphia, United States$82.8M
A biotechnology company developing gene therapy treatments for rare, debilitating genetic diseases.
- Website
Rocket Pharmaceuticals57BiotechnologyCranbury, USA$382.9MA biotechnology company developing genetic therapies for rare disorders.
- Website
Verve Therapeutics56BiotechnologyCambridge, USA$300.0MDeveloping gene editing therapies to lower cholesterol.
- Website
Verdiva Bio54BiotechnologySan Diego, United States$170.0MClinical-stage biopharmaceutical company developing next-generation therapies for obesity and cardiometabolic diseases.
- Website
Ray Therapeutics53BiotechnologyBerkeley, USA$243.0MPioneering vision restoration therapies for severe retinal degenerations.
- Website COContraline48BiotechnologyCharlottesville, USA$102.5M
Developing novel male contraceptives.
- Website SCScinus Group47BiotechnologyUtrecht, Netherlands$3.0M
Develops and distributes bioreactor technology for stem cell cultivation.
- Website HIHistoSonics47BiotechnologyMinneapolis, USA$40.0M
Developing a new histotripsy therapeutic platform for cancer treatment.
- Website
Rejoni46BiotechnologyBedford, USA$25.0MElevating uterine health through innovative biomaterial therapies.
- Website
Efferon45BiotechnologyTel Aviv, Israel$17.5MDevelops multimodal hemoadsorption therapeutic devices for sepsis and septic shock.
- Website
Turn Therapeutics38BiotechnologyLos Angeles, USA$25.0MA clinical-stage dermatology company developing novel therapies for inflammatory skin diseases.
- Website
Moderna77BiotechnologyCambridge, United States$4.5BModerna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.
- Website
KaliVir Immunotherapeutics, Inc.57BiotechnologyPittsburgh, United States$14.0MClinical-stage biotechnology company developing multi-mechanistic oncolytic immunotherapy programs for cancer treatment.
- Website
Degron Therapeutics62BiotechnologySan Diego, USA$40.0MClinical-stage biotechnology company advancing molecular glue degrader (MGD) medicines.
- Website
Enterome60BiotechnologyParis, France$123.9MClinical-stage biopharmaceutical company developing microbiome-derived immunotherapies for cancer and immune diseases.
- Website
CellCentric60BiotechnologyCambridge, United Kingdom$375.0MA clinical-stage biotechnology company developing inobrodib as a first-in-class, oral p300/CBP inhibitor for the treatment of multiple myeloma.
- Website
Infinimmune60BiotechnologyAlameda, United States$75.0MDeveloping human-derived antibodies for inflammatory diseases and cancer using AI and proprietary platforms.
- Website
LifeMine Therapeutics Inc.60BiotechnologyWatertown, United States$543.0MClinical-stage biopharmaceutical company leveraging a proprietary platform to discover and develop novel precision medicines from fungi.
Showing the 20 closest matches. See the rest on the SonoThera profile.
SonoThera alternatives: common questions
What are the closest alternatives to SonoThera?
Spark Therapeutics, HistoSonics are the closest alternatives to SonoThera by feature overlap and category. Each one is compared above on pricing, features and community sentiment.
Compare SonoThera head to head
Side by side on what each one does, what it costs, and what real users report.